Funds and ETFs Bristol-Myers Squibb Company

BMY

US1101221083

Name	Weight	AuM	1st Jan change	Investor Rating
RBC QUANT U.S. EQUITY LEADERS ETF - USD	0.78%	3 M€	+15.16%	-
HAMILTON ENHANCED MULTI-SECTOR COVERED CALL ETF - CAD	0.77%	0 M€	+5.42%	-
SPDR STOXX GLOBAL LOW VOLATILITY UCITS ETF (ACC) - USD	0.68%	5 M€	-.--%	-
FIRST TRUST EQUITY COMPASS RISK MANAGER ETF - USD	0.67%	8 M€	+5.48%	-
ISHARES ESG MSCI USA LEADERS INDEX ETF - CAD	0.63%	2 M€	+14.69%	-
NEXT FUNDS S&P 500 ESG INDEX EXCHANGE TRADED FUND - JPY	0.62%	0 M€	+18.44%	-
HARTFORD MULTIFACTOR US EQUITY ETF - USD	0.61%	0 M€	+7.46%
FIDELITY U.S. DIVIDEND FOR RISING RATES CURRENCY NEUTRAL INDEX ETF - CAD	0.60%	0 M€	+6.22%	-
GOLDMAN SACHS ACTIVEBETA US LARGE CAP EQUITY UCITS ETFC- USD	0.56%	0 M€	+9.11%
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR	0.55%	0 M€	-.--%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF	0.55%	0 M€	+8.31%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD	0.55%	0 M€	+11.06%
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - ACC - EUR	0.54%	414 M€	+11.14%	-
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - DIST - EUR	0.54%	1,006 M€	-.--%	-
FIDELITY U.S. VALUE CURRENCY NEUTRAL INDEX ETF - CAD	0.49%	0 M€	+12.62%
OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A - EUR HEDGED	0.49%	0 M€	+4.95%	-
OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A (EUR) - EUR	0.49%	0 M€	+8.05%
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (D) - EUR	0.48%	29 M€	-.--%	-
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (C) - EUR	0.48%	322 M€	+13.88%	-
REVERE SECTOR OPPORTUNITY ETF - USD	0.48%	6 M€	+17.98%	-
V-SHARES US LEADERSHIP DIVERSITY ETF - USD	0.48%	1 M€	+0.04%
AGILITY SHARES MANAGED RISK ETF - USD	0.48%	0 M€	+6.54%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DIST - USD	0.47%	1,174 M€	+23.54%
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DAILY HEDGED TO EUR - ACC - HEDGED EUR	0.47%	273 M€	-.--%
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.47%	655 M€	-.--%	-
AMUNDI S&P 500 ESG UCITS ETF EUR HEDGED ACC - EUR	0.47%	559 M€	+14.30%	-
AMUNDI S&P 500 ESG UCITS ETF ACC - EUR	0.47%	1,848 M€	+18.39%	-
LYXOR MSCI USA CLIMATE CHANGE UCITS ETF - USD	0.45%	36 M€	+22.19%
VANECK SUSTAINABLE WORLD EQUAL WEIGHT UCITS ETF - EUR	0.45%	0 M€	+8.02%
NEXT FUNDS S&P 500 (UNHEDGED) ETF - JPY	0.43%	0 M€	+18.93%	-
VANECK MULTI-ASSET GROWTH ALLOCATION UCITS ETF - EUR	0.40%	0 M€	+3.13%	-

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

Pharmaceuticals

Calendar

13/05/2024 - Guggenheim Healthcare Talks Radiopharmaceuticals Day

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

43.67 USD

Average target price

53.19 USD

Spread / Average Target

+21.81%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BRISTOL-MYERS SQUIBB COMPANY	-14.44%	88.52B
ELI LILLY AND COMPANY	+32.49%	698B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.64%	358B
MERCK & CO., INC.	+19.04%	328B
ABBVIE INC.	+3.52%	283B
ASTRAZENECA PLC	+16.34%	238B
NOVARTIS AG	+6.68%	203B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+8.15%	165B

Other Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 17:26:22 09/05/2024 BST			5-day change	1st Jan Change
43.88 ^USD	+0.47%		+0.46%	-14.44%

11:25am	India's Alembic Pharma posts higher Q4 profit on strong N.America sales	RE
05-07	Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	MT